Oscar Health raises $165M in a round led by Founders Fund with participation from Alphabet's Capital G and Verily; sources say funding brings valuation to $3.2B
- Oscar Health's valuation is now at more than $3 billion, sources say, after it raised another big round from Alphabet, Founders Fund and others.
Context & Ripple Effects
Oscar Health's raise extends a steady climb: the insurer was valued at $1.5B in its 2015 round, moved to $1.75B when Google Capital put in $32.5M that September, and hit $2.7B in Fidelity's $400M round in early 2016. At $3.2B, this Founders Fund-led round marks roughly a doubling in three years.
What makes this round notable is who is back: Alphabet participates through both Capital G and Verily, converting its earlier minority stake into a two-pronged position spanning insurance capital and health-data research — a pairing CEO Mario Schlosser would soon frame around how health care data can transform the industry in his post-investment interview.
First-order effects
- Founders Fund takes the lead seat at a $3.2B valuation while Alphabet's Capital G and Verily deepen an existing position, giving Oscar fresh runway for its direct-to-consumer insurance expansion.
Second-order effects
- Alphabet's dual-fund involvement sets a template other large insurers' challengers must answer — either find their own strategic tech backers or compete against a rival whose underwriting is subsidized by a search-and-data balance sheet.
Third-order effects
- If the pattern holds, health insurance consolidates around startups structured as data companies first and underwriters second, with big-tech strategic investors shaping which models get funded — a trajectory the corpus bears out in Oscar's later $225M raise in June 2020 and the $140M Tiger Global round that December.
The trend: Health insurance is being rebuilt as a data business funded by successive mega-rounds, with strategic tech investors like Alphabet increasingly setting the terms.